Barton J. Bradbury

Statistics

Publications

Citations

539

H-Index

Active since

1981

Affiliations

Achillion Pharmaceuticals (United States)(Current)

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Barton J. Bradbury is an author at Achillion Pharmaceuticals (United States) specializing in medicinal chemistry, pharmacology, and novel antibacterial agents.

Publications per year

1981–2011

Publications

Selenophene-Containing Inhibitors of Type IIA Bacterial Topoisomerases

Jason A. Wiles, Avinash Phadke, Barton J. Bradbury et al. · Journal of Medicinal Chemistry · 2011 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

In Vitro and In Vivo Profiles of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens

Michael J. Pucci, Steven D. Podos, Jane A. Thanassi et al. · Antimicrobial Agents and Chemotherapy · 2011 · 54 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Isothiazoloquinolones with Enhanced Antistaphylococcal Activities against Multidrug-Resistant Strains: Effects of Structural Modifications at the 6-, 7-, and 8-Positions

Qiuping Wang, Edlaine Lucien, Akihiro Hashimoto et al. · Journal of Medicinal Chemistry · 2006 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Small molecule inhibitors of E. coli primase, a novel bacterial target

Atul Agarwal, Shirley Louise‐May, Jane A. Thanassi et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 44 citations

Life Sciences, Biochemistry, Microbiology +14

Isothiazoloquinolones containing functionalized aromatic hydrocarbons at the 7-position: Synthesis and in vitro activity of a series of potent antibacterial agents with diminished cytotoxicity in human cells

Jason A. Wiles, Qiuping Wang, Edlaine Lucien et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 17